1, 8-Cineol Protect Against Influenza-Virus-Induced Pneumonia in Mice
暂无分享,去创建一个
Yan-ni Lai | F. Zhang | Yun Li | Ni Liu | Pei-Ping Xu | Yao Wang | Feng-xue Zhang | Peiping Xu
[1] F. Hayden,et al. Antiviral combinations for severe influenza , 2014, The Lancet Infectious Diseases.
[2] R. Webster,et al. Evolution and ecology of influenza A viruses. , 1992, Current topics in microbiology and immunology.
[3] H. Sudhoff,et al. 1,8-Cineol inhibits nuclear translocation of NF-κB p65 and NF-κB-dependent transcriptional activity. , 2013, Biochimica et biophysica acta.
[4] Jianbo Sun,et al. 1,8-Cineol Attenuates LPS-Induced Acute Pulmonary Inflammation in Mice , 2013, Inflammation.
[5] Andrea Rückle,et al. The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus. , 2013, Antiviral research.
[6] G. A. de Castro Brito,et al. 1,8-cineole (eucalyptol) ameliorates cerulein-induced acute pancreatitis via modulation of cytokines, oxidative stress and NF-κB activity in mice. , 2013, Life sciences.
[7] O. Planz,et al. Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro. , 2013, Antiviral research.
[8] Anna Mummert,et al. A Perspective on Multiple Waves of Influenza Pandemics , 2013, PloS one.
[9] Kyung-Hyun Cho,et al. 1,8-cineole protected human lipoproteins from modification by oxidation and glycation and exhibited serum lipid-lowering and anti-inflammatory activity in zebrafish. , 2012, BMB reports.
[10] Zhifeng Liu,et al. The Effects of the Combination of Sodium Ferulate and Oxymatrine on Lipopolysaccharide-Induced Acute Lung Injury in Mice , 2012, Inflammation.
[11] Jianhui Xie,et al. Oral administration of patchouli alcohol isolated from Pogostemonis Herba augments protection against influenza viral infection in mice. , 2012, International immunopharmacology.
[12] Y. Shu,et al. Adaption of Seasonal H1N1 Influenza Virus in Mice , 2011, PloS one.
[13] P. Roncalés,et al. Chemical composition and antimicrobial effects of essential oils of Eucalyptus globulus, Myrtus communis and Satureja hortensis against Escherichia coli O157:H7 and Staphylococcus aureus in minced beef , 2011, Food science and technology international = Ciencia y tecnologia de los alimentos internacional.
[14] R. Pagán,et al. Chemical composition and antimicrobial activity of essential oils of Thymus algeriensis, Eucalyptus globulus and Rosmarinus officinalis from Morocco. , 2011, Journal of the science of food and agriculture.
[15] Dong-Hyun Kim,et al. Artemisia princeps Pamp. Essential oil and its constituents eucalyptol and α-terpineol ameliorate bacterial vaginosis and vulvovaginal candidiasis in mice by inhibiting bacterial growth and NF-κB activation. , 2011, Planta medica.
[16] J. Reichling,et al. Antibacterial activity of essential oils from Eucalyptus and of selected components against multidrug-resistant bacterial pathogens , 2011, Pharmaceutical biology.
[17] B. Wei,et al. 8-Prenylkaempferol Suppresses Influenza A Virus-Induced RANTES Production in A549 Cells via Blocking PI3K-Mediated Transcriptional Activation of NF-κB and IRF3 , 2011, Evidence-based complementary and alternative medicine : eCAM.
[18] R. Nagatomi,et al. Procaterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. , 2011, European journal of pharmacology.
[19] H. Yen,et al. Host response to influenza virus: protection versus immunopathology. , 2010, Current opinion in immunology.
[20] Nam-Joo Lee,et al. Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009. , 2009, Antiviral research.
[21] D. Viemann,et al. Essential Impact of NF-κB Signaling on the H5N1 Influenza A Virus-Induced Transcriptome1 , 2009, The Journal of Immunology.
[22] H. Worth,et al. Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial , 2009, Respiratory research.
[23] O. Planz,et al. Role of Hypercytokinemia in NF-κB p50-Deficient Mice after H5N1 Influenza A Virus Infection , 2008, Journal of Virology.
[24] Samson S. Y. Wong,et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus , 2008, Proceedings of the National Academy of Sciences.
[25] Thorsten Wolff,et al. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF‐κB‐inhibiting activity , 2007, Cellular microbiology.
[26] Guo-hua Lu,et al. Inhibitory effect of 1,8-cineol (eucalyptol) on Egr-1 expression in lipopolysaccharide-stimulated THP-1 cells , 2007, Acta Pharmacologica Sinica.
[27] W. Seeger,et al. Alveolar fluid clearance in acute lung injury: what have we learned from animal models and clinical studies? , 2007, Intensive Care Medicine.
[28] P. Doherty,et al. A question of self‐preservation: immunopathology in influenza virus infection , 2007, Immunology and cell biology.
[29] G. He,et al. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. , 2006, American journal of respiratory and critical care medicine.
[30] Yi Guan,et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.
[31] M. Severa,et al. Tumor Necrosis Factor Alpha Enhances Influenza A Virus-Induced Expression of Antiviral Cytokines by Activating RIG-I Gene Expression , 2006, Journal of Virology.
[32] P. Österlund,et al. TNF-α and IFN-α enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells , 2006 .
[33] P. Österlund,et al. TNF-alpha and IFN-alpha pretreatment enhances influenza A virus-induced chemokine gene expression in lung epithelial cells , 2006 .
[34] E. De Clercq,et al. Antiviral agents active against influenza A viruses , 2006, Nature reviews. Drug discovery.
[35] Y. Guan,et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells , 2005, Respiratory research.
[36] A. Gillissen,et al. Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes. , 2004, Pulmonary pharmacology & therapeutics.
[37] R. C. L. Lima Júnior,et al. 1,8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[38] A. Gillissen,et al. Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial. , 2003, Respiratory medicine.
[39] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[40] D. Gemsa,et al. Defense against influenza A virus infection: essential role of the chemokine system. , 2001, Immunobiology.
[41] K. Melén,et al. Inflammatory responses in influenza A virus infection. , 2000, Vaccine.
[42] J. Gilsdorf,et al. Induction of Proinflammatory Cytokines from Human Respiratory Epithelial Cells after Stimulation by NontypeableHaemophilus influenzae , 2000, Infection and Immunity.
[43] F. Santos,et al. Antiinflammatory and antinociceptive effects of 1,8‐cineole a terpenoid oxide present in many plant essential oils , 2000, Phytotherapy research : PTR.
[44] N. Maeda,et al. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. , 2000, The American journal of pathology.
[45] W G Alvord,et al. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. , 1999, The Journal of infectious diseases.
[46] H. Vetter,et al. Inhibition of cytokine production and arachidonic acid metabolism by eucalyptol (1.8-cineole) in human blood monocytes in vitro. , 1998, European journal of medical research.
[47] E. Abraham,et al. Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. , 1998, Journal of immunology.
[48] M. Karin,et al. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.
[49] P. Baeuerle,et al. Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.
[50] R. Lamb,et al. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block , 1993, Journal of virology.
[51] C. Smith,et al. Induction of ICAM-1 expression on human airway epithelial cells by inflammatory cytokines: effects on neutrophil-epithelial cell adhesion. , 1992, American journal of respiratory cell and molecular biology.
[52] C B Hall,et al. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection , 1988, Journal of virology.